Management of Celiac Arterial Stenosis

Etiology and Clinical Presentation

• The American College of Radiology suggests that celiac arterial stenosis can be caused by median arcuate ligament (MAL) compression, which is present in approximately 20% of the population, and atherosclerotic disease [1] [2]
• Common symptoms of celiac arterial stenosis include postprandial abdominal pain, nausea and vomiting that worsens after meals, and fear of eating (sitophobia), as reported by the American College of Radiology [1] [3]

Diagnostic Approach

• The American College of Radiology recommends CT angiography (CTA) as the initial imaging modality of choice, looking for proximal narrowing of the celiac artery in a "J-shaped" configuration (in MAL syndrome), atherosclerotic changes, and presence of collateral circulation [1] [2]
• Mesenteric angiography with lateral projection during both inspiration and expiration can demonstrate dynamic worsening of stenosis on expiration (in MAL syndrome) and identify mesenteric collateralization, as suggested by the American College of Radiology [1] [4]

Management Algorithm

• The American College of Radiology recommends surgical release of the median arcuate ligament as the first-line treatment for median arcuate ligament syndrome, which is associated with symptomatic relief in 84.6% of patients [1] [2]
• Additional revascularization after MAL release may be considered if residual stenosis of the celiac artery is greater than 30%, with options including endovascular stent placement and surgical bypass creation, as reported by the American College of Radiology [1] [4]
• For atherosclerotic celiac stenosis, the American College of Radiology suggests endovascular therapy (angioplasty with stent placement) as the first-line treatment, with technical success rates of 85-100% and lower perioperative risks compared to open surgical intervention [1] [2] 3

Special Considerations

• The American College of Radiology notes that not all patients with imaging evidence of celiac compression are symptomatic, and compression may be a normal finding in up to 20% of the population 3
• Alternative diagnoses should be considered if symptoms persist after intervention, as celiac compression may be an incidental finding rather than the cause of symptoms, as suggested by the American College of Radiology 3

Pitfalls and Caveats

• The American College of Radiology warns that endovascular intervention alone (without surgical release) is not recommended for MAL syndrome due to persistent extrinsic compression, chronic changes to the vessel wall, and risk of stent fracture or migration [3] [4]
• Systemic anticoagulation has limited data to support its use in patients with MAL compression without evidence of thrombosis, as reported by the American College of Radiology 1

Initial Treatment Approach for Median Arcuate Ligament Syndrome

Initial Treatment Algorithm

• The American College of Radiology recommends supportive treatment with analgesics and continued diagnostic evaluation for alternate causes of abdominal pain as the reasonable first steps in patients with suspected median arcuate ligament syndrome 5, 6, 7
• Predictors of successful surgical outcomes include postprandial pain pattern, with an 81% cure rate, age between 40-60 years, with a 77% cure rate, and weight loss of 20 pounds or more, with a 67% cure rate 5, 6, 7
• A combined approach of celiac decompression and celiac artery revascularization when needed is recommended, with the American College of Radiology suggesting that best results are seen in patients who receive both 5, 6, 7
• Endovascular stent placement alone is not recommended and may be contraindicated unless ligament release has been performed first, according to the American College of Radiology 5, 6, 7

Management of Celiac Artery Stenosis with Abdominal Pain

Diagnostic Workup and Management Algorithm

• For suspected median arcuate ligament syndrome, mesenteric angiography in lateral projection during both inspiration and expiration should be performed to demonstrate dynamic worsening of stenosis on expiration, and to evaluate for the presence of other mesenteric vessel involvement, which significantly impacts treatment decisions, according to the American College of Radiology 8
• Surgical bypass or endarterectomy is rated as appropriate (rating 7/9) but is typically reserved for patients unsuitable for endovascular intervention or when combined with other abdominal surgery, as stated by the American College of Radiology 8
• Angiography with percutaneous transluminal angioplasty and stent placement is rated as usually appropriate (8/9) for multi-vessel disease requiring urgent intervention, according to the American College of Radiology 8
• Surgical bypass or endarterectomy is also appropriate (7/9) as an alternative for multi-vessel disease requiring urgent intervention, as rated by the American College of Radiology 8
• Systemic anticoagulation alone (rating 5/9) may be complementary but should not be done as sole therapy for multi-vessel disease requiring urgent intervention, according to the American College of Radiology 8

Guideline Recommendations for Celiac Artery Occlusion Management

1. Presentation‑Driven Management Strategy

• Endovascular therapy is the first‑line treatment for most symptomatic celiac artery occlusions, while asymptomatic occlusions require no intervention. European Society of Cardiology (ESC) guidance rates this approach as “usually appropriate.” 9
• The choice between acute and chronic presentation determines the urgency and type of revascularization required. ESC recommends immediate revascularization for acute occlusion with threatened bowel ischemia. 10

2. Chronic Symptomatic Celiac Artery Occlusion

2.1 First‑Line Endovascular Revascularization

• Percutaneous transluminal angioplasty (PTA) with stent placement, performed under angiographic guidance, is the preferred initial therapy, receiving an 8/9 appropriateness rating (≈ “usually appropriate”). American College of Radiology (ACR). 11
• Compared with open surgical repair, endovascular therapy shows markedly lower peri‑operative mortality (odds ratio 0.20; 95 % CI 0.17–0.24). ESC. 9

2.2 Surgical Bypass or Endarterectomy (Alternative)

• Surgical bypass or endarterectomy is rated 6–7/9 (“may be appropriate”) and is reserved for patients in whom endovascular access is not feasible. ACR. 12
• When feasible, surgical reconstruction provides superior long‑term vessel patency and fewer re‑interventions than endovascular therapy. ESC. 10

2.3 Adjunctive Anticoagulation

• Systemic anticoagulation alone is rated only 5/9 (“may be appropriate”) and should not be used as sole therapy for atherosclerotic celiac occlusion. ACR. 11
• Anticoagulation may be added as a complementary measure to either endovascular or surgical revascularization. ACR. 12

3. Median Arcuate Ligament Syndrome (MALS)

3.1 Diagnostic Confirmation

• Dynamic mesenteric angiography in lateral projection during both inspiration and expiration is required to demonstrate extrinsic compression of the celiac artery. ACR. 11

3.2 First‑Line Treatment

• Surgical release of the median arcuate ligament is the recommended first‑line therapy, receiving an 8/9 appropriateness rating. ACR. 12

3.3 Role of Endovascular Stenting

• Endovascular stent placement without prior ligament release is rated only 4/9 and is not recommended because persistent extrinsic compression can lead to stent fracture or migration. ACR. 11

4. Asymptomatic Celiac Artery Occlusion

• No therapeutic intervention is indicated for incidentally discovered asymptomatic occlusion, irrespective of imaging severity. ESC guidance rates observation as appropriate (7/9). 9

5. Acute Celiac Artery Occlusion

5.1 Immediate Revascularization

• When acute occlusion threatens bowel viability, urgent revascularization is mandatory. ESC. 10

5.2 Preferred Modality

• Endovascular therapy is the preferred first‑line approach for acute thrombotic occlusion (Class IIa recommendation). ESC. 9

5.3 Contraindications to Immediate Intervention

• Revascularization may be deferred only in the presence of severe peritonitis or septic shock. ESC. 10

6. Critical Clinical Pitfalls

• Delaying revascularization in chronic mesenteric ischemia to improve nutritional status is associated with clinical deterioration, bowel infarction, and sepsis. ESC. 9
• Relying on systemic anticoagulation as the sole therapy for atherosclerotic celiac occlusion is ineffective and not recommended. ACR. 12
• In patients with multi‑vessel mesenteric disease, both the celiac artery and superior mesenteric artery may require simultaneous treatment. ACR. 11